Class of Stock [Axis]
Common Class A [Member]
Common Class B [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Sale of Stock [Axis]
IPO [Member]
Warrant [Member]
Investment, Name [Axis]
MDB Minnesota One Inc [Member]
Mayo Foundation [Member]
Debt Instrument [Axis]
SAFE [Member]
Credit Facility [Axis]
Revolving Credit Facility [Member]
Award Type [Axis]
Broker Dealer [Member]
Warrants of Publicly Traded Companies [Member]
Warrants of Non Publicly Traded Companies [Member]
Non Broker Dealer [Member]
Simple Agreement on Future Equities [Member]
Impairment [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Weighted Average [Member]
Long-Lived Tangible Asset [Axis]
Laboratory Equipment [Member]
Developed Software [Member]
Furniture and Fixtures [Member]
Leasehold Improvements [Member]
Segments [Axis]
Broker Dealer And Intellectual Property Service [Member]
Technology Development [Member]
Other [Member]
Eliminations [Member]
Broker Dealer & Intellectual Property Service [Member]
Ownership [Axis]
Minnesota One [Member]
Exozyme Technologies Inc [Member]
Legal Entity [Axis]
Exozymes Inc [Member]
Consolidated Entities [Axis]
Exozymes [Member]
Invizyne Technologies Inc [Member]
Restricted Stock Units (RSUs) [Member]
Private Placement [Member]
Market Based [Member]
Time Based [Member]
Antidilutive Securities [Axis]
Related and Nonrelated Parties [Axis]
ENDRA [Member]
Title and Position [Axis]
Public Ventures [Member]
DTC Membership Requirements [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
License Agreement [Member]
Phase II clinical [Member]
Phase III clinical [Member]
New Drug Application First [Member]
New Drug Application [Member]
Income Tax Authority, Name [Axis]
U.S Federal Tax [Member]
Florida Income Tax [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Statement [Table]
Statement [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Auditor Name
Auditor Location
Auditor Firm ID
Auditor Opinion [Text Block]
Assets
Cash and cash equivalents
Cash segregated in compliance with regulations
Accounts receivable
Related party receivables
Clearing deposits
Prepaid expenses and other current assets
Investment securities, at fair value, held by the licensed broker dealer (Notes 1 and 2)
Investment securities, at fair value, held by the non-licensed broker dealer (Notes 1 and 2)
Equity method investment
Deferred costs related to deferred revenue
Property and equipment, net
Operating lease right-of-use asset, net
Total assets
LIABILITIES AND EQUITY
Liabilities:
Accounts payable
Accrued expenses
Related party payables
Payables to customers
Operating lease liabilities
Total liabilities
Commitments and Contingencies (Note 10)
Equity:
Preferred shares, 10,000,000 authorized shares at no par value; 0 issued and outstanding
Common stock, value
Additional paid-in-capital
Accumulated income (deficit)
Total MDB Capital Holdings, LLC equity
Non-controlling interest
Total equity
Total liabilities and equity
Preferred stock, shares authorized
Preferred stock, no par value
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, shares authorized
Common stock, no par value
Common stock, shares issued
Common stock, shares outstanding
Operating income:
Unrealized (loss) on investment securities, net from the licensed broker dealer (Notes 1 and 2)
Unrealized gain on investment securities, net from non-licensed broker dealer (Notes 1 and 2)
Realized gain on investment securities, net from the licensed broker dealer
Fee income (from our licensed broker dealer)
Impairment of investment securities
Other operating income
Total operating income, net
Operating costs:
General and administrative costs:
Compensation
Operating expense, related party
Professional fees
Information technology
Clearing and other charges
General and administrative-other
Total general and administrative costs
Research and development costs, net of grants $0 and $2,003 in 2024 and 2024
Total operating costs
Net operating loss
Other income and expenses:
Miscellaneous income
Interest income
Interest expense
Gain related to dilution events
Gain on deconsolidation of subsidiary
Net income (loss) before income taxes
Income taxes
Net income (loss) before equity method investee
Equity in loss of equity method investee
Net income (loss)
Less net loss attributable to non-controlling interest
Net income (loss) attributable to MDB Capital Holdings, LLC
Income (loss) per share attributable to MDB Capital Holdings, LLC:
Income (loss) per Common Share – basic
Weighted average of number Common Shares outstanding – basic
Income (loss) per Common Share –diluted
Diluted number of Common Shares outstanding
Income Statement [Abstract]
Research and development, Grants
Balance
Balance, shares
Issuance of Class A Common Shares
Issuance of Class A Common Shares, shares
Stock-based compensation
Net income (loss)
Ownership change of non-controlling interest
Effect of deconsolidation of subsidiary
Balance
Balance, shares
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Unrealized loss on investment securities, net
Accretion of investments at amortized cost (U.S Treasury Bills)
Realized loss (gain) on investment securities, net from the licensed broker dealer
Stock-based compensation
Effect of deconsolidation of subsidiary
Depreciation of property and equipment
Deferred costs related to revenue
Dilution of deferred grant reimbursement
Gain on deconsolidation
Portion of loss from equity investment
Gain related to dilution events
Warrants issued as part of an investment banking deal
Share of loss from equity method investment
Income recognized from warrants received
Impairment of investment securities
Deferred revenue
Change in ROU Asset
Change in lease liability
Changes in operating assets and liabilities:
(Increase) decrease in -
Grants receivable
Accounts receivable
Related party receivables
Prepaid expenses and other current assets
Clearing deposits
Increase (decrease) in -
Accounts payable
Accrued expenses
Related party payables
Payables to customers
Payables to non-customers
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of investment securities, at amortized cost (U.S. Treasury Bills)
Proceeds from payments and maturities of investment securities, at amortized cost (U.S. Treasury Bills)
Accretion of equity investments
Deferred grant reimbursement
Purchases of property and equipment
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Acquisition of non-controlling interest
Net cash provided by financing activities
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR
CASH AND CASH EQUIVALENTS - END OF YEAR
Supplemental disclosures of cash flow information:
Income taxes
Non-cash investing and financing activities:
Warrants received as part of an investment banking deal
Relinquishment of deferred costs of initial public offering from prior year
Investment securities, at cost less impairment, received in lieu of cash payment
Issuance of warrants to purchase Class A stock related to the initial public offering closed on September 20, 2023
Cash segregated in compliance with regulations
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
No insider trading flag
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Accounting Policies [Abstract]
Organization and Description of Business
Summary of Significant Accounting Policies
Segment Reporting [Abstract]
Segment Reporting
Equity [Abstract]
Equity and Non-Controlling Interests
Deconsolidation
Deconsolidation
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investment
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation
Earnings Per Share [Abstract]
Earnings Per Share
Related Party Transactions [Abstract]
Related Party Transactions
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Retirement Benefits [Abstract]
Employee Benefit Plans
Exclusive License Agreement
Exclusive License Agreement (MDB Minnesota One)
Leases
Leases
Income Tax Disclosure [Abstract]
Income Taxes
Subsequent Events [Abstract]
Subsequent Events
Basis of Presentation and Principles of Consolidation
Deconsolidation
Equity method investment
Income Taxes
Use of Estimates
Emerging Growth Company
Cash and Cash Equivalents
Segregated Cash and Deposits
Clearing Deposits
Prepaid and other current assets
Leases
Stock Based Compensation
Investment Securities
Fair Value of Financial Instruments
Secured Debt–- Revolving Credit Facility
Property and Equipment
Revenue
Research Grants
Research and Development Costs
Patent and Licensing Legal and Filing Fees and Costs
Recently Issued Accounting Pronouncements
Schedule of Investment Securities Broker Dealer
Schedule of Investment Securities Non-Broker Dealer
Schedule of Fair Value of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Schedule of Reconciliation of Fair Value Measurements Within Level 3 of Fair Value Hierarchy
Schedule of Significant Unobservable Inputs Related to Material Components of Level 3 Warrants
Schedule of Estimated Useful Lives of Property and Equipment
Schedule of Property And Equipment
Schedule of Changes in Deferred Revenue
Summary of Grants Receivable Activity
Schedule of Long-lived Assets and Total Assets by Segment
Schedule of Statement of Operation by Segment
Schedule of Equity and Non-Controlling Interests
Schedule of Consolidated Balance Sheet
Schedule of Gain on Deconsolidation
Schedule of Equity Method Investment
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Restricted Stock Unit Activity
Schedule of Market-Based Stock Option Activity
Schedule of Basic and Fully Diluted
Schedule of Operating Lease Cost
Schedule of Future payments Due Under Operating Lease
Schedule of Income Taxes Expenses (benefit)
Schedule of Deferred Tax Assets and Liabilities
Schedule of Deferred Tax Assets and Liabilities
AccountingPoliciesTable [Table]
AccountingPolicies [Line Items]
Sale of stock, number of shares issued in transaction
Sale of stock, price per share
Gross proceeds
Net proceeds
Offering expenses
Warrants to puchase common shares
Contract life
Exercise price of warrants
Common stock price
Warrants fair value
Exercise price
Estimated life
Risk-free rate
Expected annual volatility
Annual rate of dividends
Ownership percentage
Up-front fees
Investments
Cash equivalents
Cash, FDIC insured limits
Cash, SIPC insured limits
Unsegregated cash
Cash uninsured limits
Revolving credit, maximum borrowing capacity
Deposits
Prepaid and other expenses
Intangible assets acquired
Prepaid professional fees
Security deposit
Prepaid insurance
Various prepaid expense
Other assets
Net unrealized gain (loss) on investment securities
Impairment of securities
Maturity date
Variable rate
Interest rate
Credit non-usage fee
Outstanding indebtedness
Interest payable
Research and development costs
Grant drawdowns
Net of grant received
Patent and licensing legal and filing fees and costs
Investment securities, at fair value
Investment securities, at cost less impairment
Platform Operator, Crypto Asset [Table]
Platform Operator, Crypto Asset [Line Items]
Investment securities, at fair value, held by the non-licensed broker dealer
Beginning Balance
Receipt from investment banking fees
Unrealized (loss) gains
Ending Balance
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Warrants, Fair value
Weighted measurement input
Property and equipment, estimated useful lives
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]
Developed software
Total property and equipment
Less: Accumulated depreciation
Property and equipment, net
Deferred revenue, Balance
Amounts billed but not recognized
Revenue recognized
Deferred revenue, Balance
Balance at beginning of year
Grant costs expensed
Grants for equipment purchased
Grant fees
Grant funds received
Removal of balance due to deconsolidation of eXoZymes at November 14, 2024
Balance at end of year
Schedule of Segment Reporting Information, by Segment [Table]
Segment Reporting Information [Line Items]
Long-lived assets
Total assets
Unrealized (loss) on investment securities, net from the licensed broker dealer
Investment securities, at fair value, held by the non-licensed broker dealer (1)
Realized gain on investment securities, net from the licensed broker dealer
Fee income from the licensed broker dealer
Impairment loss
Compensation
Operating expense, related party
Research and development costs
Total operating costs
Other income and expense:
Gain on deconsolidation of subsidiary
Income tax expense
Income (loss) before equity method investee
Less net loss attributable to non-controlling interests
Unrealized (loss) on investment securities, net from the licensed broker dealer
Number of reportable segments
EquityTable [Table]
Equity [Line Items]
Non-controlling net loss
Weighted average non-controlling percentage
Net loss non-controlling interest
Prior period balance
Removal of prior period balance of Exozyme due to deconsolidation
Stock-based compensation
Ownership change of non-controlling interest
Ending period balance
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Common stock, shares, issued
Common stock, shares, outstanding
Placement agent and selling agent warrants
Ownership interest rate
Non-controlling interest rate
Capital infusions
Equity interest rate
DeconsolidationTable [Table]
Equity method, net loss
Net loss
Current assets
Current liabilities
Total liabilities
Revenues
ScheduleOfConsolidatedBalanceSheetTable [Table]
Grants receivable
Deferred IPO Costs
Accounts payable
Due to affiliates
Deferred grant reimbursement
Common shares
Paid-in-capital
Accumulated deficit
ScheduleOfGainOnDeconsolidationTable [Table]
Subtotal of quoted closing price of Class A common shares
Quoted closing price of Class A common shares
Fair value of warrants
Fair value of equity method investment
Carrying Value of the NCI
Carrying value of assets
Less carrying value of former investment
Carrying value of warrants
Gain on deconsolidation
Equity method investments, balance
Portion of loss from Invizyne
Gain related to dilution events
Equity method investments, balance
Equity Method Investment [Table]
Schedule of Equity Method Investments [Line Items]
Equity method investment, percentage
Owned shares
Number of Restricted Stock Units, outstanding
Weighted Average Grant Date Fair Value, outstanding
Number of Restricted Stock Units, outstanding
Weighted Average Grant Date Fair Value, outstanding
Number of Restricted Stock Units, outstanding
Weighted Average Grant Date Fair Value, outstanding
Number of Restricted Stock Units, outstanding
Number of Restricted Stock Units, Exchanged/Modified
Weighted Average Grant Date Fair Value, Exchanged/Modified
Number of Restricted Stock Units, outstanding
Weighted Average Grant Date Fair Value, outstanding
Number of Restricted Stock Units, outstanding
Weighted Average Grant Date Fair Value, outstanding
Exercisable and vested restricted stock, outstanding
Weighted Average Grant Date Fair Value, Exercisable and vested
Number of Options, time-based stock options outstanding, beginning
Weighted average exercise price, time-based stock options outstanding
Number of Options, exchanged/modified
Weighted average exercise price, exchanged/modified
Weighted average remaining contractual life (in years), time-based stock options exchanged/modified
Number of Options, exercised
Weighted average exercise price, exercised
Number of Options, expired/cancelled
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Number of Options, time-based stock options outstanding, at the end
Weighted average exercise price, time-based stock options outstanding
Weighted average remaining contractual life (in years), time-based stock options outstanding
Number of Options, stock options exercisable
Weighted average exercise price, stock options exercisable
Weighted average remaining contractual life (in years), stock options exercisable
Weighted average remaining contractual life (in years), exchanged/modified
Weighted average exercise price, expired/cancelled
Weighted average remaining contractual life (in years), market-based stock options outstanding
Stock options to purchase
Restricted stock units, description
Number of restricted stock units, canceled or forfeited
RSU vested
Unrecognized stock-based compensation
Remaining weighted average years
Cancelled shares
Number of restricted stock units, cancelled and converted
Fair value
Restricted stock unit, value
Unvested portion market value
Sharebased payment award amortized amount
Stock-based compensation term life
Exercise price per share, granted
Exercisable period
Remaining stock options vesting period
Common stock price per share
Expected annual volatility
Exercise price per share, granted
Average price per share
Exercisable period
Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net income (loss) attributable to MDB Capital Holdings, LLC
Weighted average shares outstanding – basic
Net income (loss) per share – basic
Net income (loss) attributable to MDB Capital Holdings, LLC
Diluted shares outstanding –diluted
Net income (loss) per share –diluted
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Related party expenses
Operating Expenses
Interest receivable
Accrued expenses
Value issued for services
Tax paid
Accrued liabilities
CommitmentsAndContingenciesTable [Table]
Commitments and Contingencies [Line Items]
Net capital
Loans payable
Interest expense
Percentage of aggregate indebtedness
Aggregate indebtedness calculated amount
Employer contribution
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Issuance of shares
License fee
Payments for licensed products
Schedule Of Operating Lease Cost
Right-of-use assets
Weighted average remaining lease term in years
Weighted average discount rate
Cash paid for amounts included in the measurement of lease liabilities
Right-of-use assets obtained in exchange for lease liabilities
Operating lease cost
Short-Term Lease, Cost
Total operating lease costs
Schedule Of Future Payments Due Under Operating Lease
2026
2027
2028
2029 and thereafter
Total
Less effects of discounting
Total operating lease liability
Initial rent, per month
Base rent, per month
Annual operating cost increase percentage
Extension term of lease
Lease term
Option to extend
Federal
State
Federal
State
Total
U.S Federal statutory income rate, Amount
U.S Federal statutory income rate, Rate
State, net of federal tax benefit, Amount
State, net of federal tax benefit, Rate
Income/loss excluded from nontaxable entities, Amount
Income/loss excluded from nontaxable entities, Rate
Permanent differences, Amount
Permanent differences, Rate
Meals and entertainment, Amount
Meals and entertainment, Rate
Stock options, Amount
Stock options, Rate
Equity award vesting, Amount
Equity award vesting, Rate
Modification of equity awards, Amount
Equity award vesting, Rate
Return-to-provision adjustments, Amount
Return-to-provision adjustments, Rate
Other, Amount
Other, Rate
Valuation allowance, Amount
Valuation allowance, Rate
Effective rate, Amount
Effective rate, Rate
U.S Federal statutory income rate, Amount
U.S Federal statutory income rate, Rate
Deferred tax assets:
Start-up expenditures
Organizational expenditures
Sec 174 – Research and development costs
Stock compensation
Lease liability
Property and equipment principally due to differences in depreciation
Bonus expense
Charitable contribution carryforwards
Impairment expense
Intangible Assets
Net operating loss carryforwards
Valuation allowance
Deferred tax assets
Deferred tax liabilities:
Right-of-use asset
Investment securities
Deferred tax liabilities
Other noncurrent assets/(liabilities)
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Line Items]
Cash taxes paid
Net operating loss carryforwards
Decrease in deferred tax assets valuation allowance
Subsequent Event [Table]
Subsequent Event [Line Items]
Restricted stock units, granted
Investment securities at fair value.
Payables to customers current and non current.
Impairment of investment securities.
Compensation costs.
Operating expense related party.
Clearing and other charges.
Net operating loss.
Miscellaneous income.
Gain related to dilution events.
Net income (loss) before equity method investee.
Equity in loss of equity method investee.
Effect of deconsolidation of subsidiary.
Accretion of investments at amortized cost (U.S Treasury Bills).
Dilution of deferred grant reimbursement.
Portion of loss from equity investment.
Proceeds from warrants issued as part of investment banking deal.
Income recognized from warrants received.
Impairment of investments securities.
Increase decrease in payables to noncustomers.
Proceeds from investments securities.
Payments to acquire investments securities.
Payment for deferred grant reimbursement.
Warrants received as part of investment banking deal.
Relienquishment of deferred costs of initial public offering from prior year.
Investment securities at cost less impairment received in lieu of cash payment.
Issuance of warrants to purchase Class A stock related to the initial public offering.
MDB Minnesota One Inc [Member]
Mayo Foundation [Member]
Deconsolidation [Policy Text Block].
Emerging Growth Company Policy [Text Block]
Segregated Cash And Deposits Policy [Text Block]
Prepaid And Other Current Assets [Policy Text Block]
Prepaid professional fees.
Schedule of Investment Securities Broker Dealer [Table Text Block]
Schedule of Investment Securities Non Broker Dealer [TableText Block].
Investment securities at cost less impairment non broker dealer.
SAFE [Member]
Fair value measurement with unobservable input reconciliation recurring basis asset gain loss included in other comprehensive income loss.
Property Plant And Equipment Estimated Useful Lives [Table Text Block]
Laboratory Equipment [Member]
Developed Software [Member]
Technology Development [Member]
Contract with customer liability amounts billed not recognized.
Accounting For Research Grants [Policy Text Block]
Tabular disclosure of grants receivable activity table text block.
Amount of grant costs expensed.
Amount of grants for equipment purchased.
Amount of grant fees.
Amount of grant funds received.
Removal of balance due to deconsolidation.
Grant drawdowns.
Research and development expense gross.
Patent And Licensing Legal And Filing Fees And Costs [Policy Text Block]
Broker Dealer & Intellectual Property Service [Member]
Other [Member]
Eliminations [Member]
Realized investment gains losses one.
Exclusive License Agreement [Text Block]
License Agreement [Member]
Payment for licensed products.
Phase II clinical [Member]
Phase III clinical [Member]
New Drug Application First [Member]
New Drug Application [Member]
Base rent.
Annual operating cost increase percentage.
Lessee operating lease liability payments due after year three.
Minnesota One [Member]
Invizyne Technologies Inc [Member]
Exozyme Technologies Inc [Member]
Deferred tax assets in startup expenditures.
Deferred tax assets stock compensation.
Deferred tax assets lease liability.
Deferred tax assets bonus expense.
Deferred tax assets impairment expense.
Deferred tax liabilities investment securities.
Deferred tax assets in organizational expenditures.
Schedule Of Equity And Non Controlling Interests [Table Text Block]
Weighted average non-controlling percentage.
Due to deconsolidation.
Share based compensation to non controlling interest.
Ownership change of non-controlling interest.
Deconsolidation Disclosure [Text Block]
Exozymes Inc [Member]
Deferred Grant Reimbursement.
Schedule Of Gain On Deconsolidation [Table Text Block]
Carrying value of assets.
Less carrying value of former investment.
Carrying value of warrants.
Gain related to dilution events.
Income loss excluded from nontaxable entities.
Provision adjustments.
Share based compensation arrangement by share based payment award equity instruments other than options expired and cancelled in period.
Market Based [Member]
Income tax reconciliation income tax expenses provision adjustments.
Sharebased compensation arrangement by sharebased payment award amortized amount.
Time Based [Member]
Share based compensation arrangement by share based payment award equity instruments other than options exchanged and modified in period
Share based compensation arrangement by share based payment award equity instruments other than options nonvested vested and expected to vest exercisable number.
Share based compensation arrangement by share based payment award equity instruments other than options exchanged and modified weighted average grant date fair value
Share based compensation arrangement by share based payment award equity instruments other than options expired and cancelled weighted average grant date fair value.
Share based compensation arrangement by share based payment award equity instruments other than options grants in vested and expected to vest exercisable weighted average exercise price.
Share based compensation arrangement by share based payment award equity instruments other than options exercised in period.
Share based compensation arrangement by share based payment award options remaining stock options vesting
Share based compensation arrangement by share based payment award options exchanged and modified in period
Equity award vesting.
Share based compensation arrangements by share based payment award options exchanged and modified in period weighted average exercise price
Share based compensation arrangement by sharebased payment award options exchanged weighted average remaining contractual term 2.
Income tax reconciliation modification of equity awards amount.
Average price per share
Share based compensation arrangement by share based payment award options exercisable weighted average remaining contractual term 1 vesting
Share based compensation arrangement by share based payment award options outstanding exchanged and modified weighted average remaining contractual term 1
ENDRA [Member]
Exozymes [Member]
Public Ventures [Member]
DTC Membership Requirements [Member]
Accrued expenses.
Income tax reconciliation equity in equity award vesting amount.
Income tax reconciliation income loss excluded from nontaxable entities.
Impairment [Member]
Simple Agreement on Future Equities [Member]
No Insider Trading Flag.
Research and development grants.
Broker Dealer And Intellectual Property Service [Member]
Cash insured amount.
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Investment securities, at fair value, held by the non-licensed broker dealer.
Unrealized gain on investment securities, net from non-licensed broker dealer.
Unrealized loss on investment securities, net from non-licensed broker dealer.
Warrants of Publicly Traded Companies [Member]
Warrants of Non Publicly Traded Companies [Member]
Non Broker Dealer [Member]
Investment securities, at fair value, held by the licensed broker dealer.
Broker Dealer [Member]
Investments securities, at fair value, held by the non-licensed broker dealer.
U.S Federal Tax [Member]
Florida Income Tax [Member]
Useful Life, Lease Term [Member]
Equity, Attributable to Parent
Equity, Including Portion Attributable to Noncontrolling Interest
Liabilities and Equity
UnrealizedLossOnInvestmentSecuritiesNetFromLicensedBrokerDealerNotes1And2
Operating Income (Loss)
General and Administrative Expense
Operating Costs and Expenses
Net operating loss
Interest Expense, Nonoperating
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Shares, Outstanding
AccretionOfInvestmentsAtAmortizedCostUSTreasuryBills
Share-Based Payment Arrangement, Noncash Expense
Proceeds from Equity Method Investment, Distribution
Increase (Decrease) in Deferred Income Taxes
Equity Method Investment, Realized Gain (Loss) on Disposal
IncomeRecognizedFromWarrantsReceived
Increase (Decrease) in Other Receivables
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Due from Related Parties, Current
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Deposit Assets
Increase (Decrease) in Other Accounts Payable
Increase (Decrease) in Accrued Liabilities
Increase (Decrease) in Due to Related Parties, Current
Increase (Decrease) in Payables to Customers
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
PaymentsToAcquireInvestmentsSecurities
Payments to Acquire Equity Method Investments
PaymentForDeferredGrantReimbursement
Payments for (Proceeds from) Productive Assets
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Income Taxes Paid, Net
Cash and Securities Segregated under Federal and Other Regulations
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Deconsolidation Disclosure [Text Block]
Lessee, Operating Leases [Text Block]
DeconsolidationPolicyTextBlock
Equity Method Investments [Policy Text Block]
Income Tax, Policy [Policy Text Block]
Lessee, Leases [Policy Text Block]
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Contract with Customer, Liability
RealizedInvestmentGainsLossesOne
Labor and Related Expense
Other Nonoperating Expense
ShareBasedCompensationToNonControllingInterest
OwnershipChangeOfNoncontrollingInterest
Accounts Payable, Other
EquityMethodInvestmentsGainRelatedToDilutionEvents
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredAndCancelledWeightedAverageGrantDateFairValue
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedVestedAndExpectedToVestExercisableNumber
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Net Income (Loss) Available to Common Stockholders, Diluted
AccruedExpenses
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Deferred Federal Income Tax Expense (Benefit)
Deferred State and Local Income Tax Expense (Benefit)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Effective Income Tax Rate Reconciliation, Percent
IncomeTaxReconciliationIncomeTaxExpenseBenefitOfFederalStatutoryIncomeTaxRate
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Deferred Tax Assets, Net of Valuation Allowance
Deferred Tax Liabilities, Other
DeferredTaxLiabilitiesInvestmentSecurities
Deferred Tax Liabilities, Net
Deferred Tax Assets, Net
Operating Loss Carryforwards